Finally, these data are from a single regional poison center, and for that reason the generalizability of our findings to other regions are limited
GHK-Cu appears safe for use in lab research and cosmetic studies
oral), and whether to continue, modify, or transition GLP-1 therapy
Distinct Tolerability Profile : This enhanced efficacy is associated with a different adverse event profile
Ex vivo, redox imbalances corresponded to 15LO1 and SLC7A11 expression, T2 biomarkers, and worsened clinical outcomes
28 They found that GLP-1 RA use was associated with a lower risk of incident glaucoma (hazard ratio [HR] = .81), with the risk decreasing even further when GLP-1 RAs were used for longer than 3 years (HR = .71)